Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.

Documenti analoghi

• Pharmacodynamics of Once-Daily Amikacin in Various Combinations with Cefepime, Aztreonam, and Ceftazidime against Pseudomonas aeruginosa in an In Vitro Infection Model
  di: McGrath, Betty J., et al.
  Pubblicazione: (1993)
• Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.
  di: McGrath, B J, et al.
  Pubblicazione: (1992)
• In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa
  di: Asempa, Tomefa E., et al.
  Pubblicazione: (2019)
• Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.
  di: Cappelletty, D M, et al.
  Pubblicazione: (1995)
• Imipenem/Cilastatin/Relebactam Alone and in Combination against Pseudomonas aeruginosa in the In Vitro Pharmacodynamic Model
  di: Chen, Iris H., et al.
  Pubblicazione: (2020)